Skip to main content
. 2020 Feb 3;10:931. doi: 10.3389/fendo.2019.00931

Figure 3.

Figure 3

Percentage (95% CI) of patients with (A) mGH <1.0 μg/L and IGF-I <1.0 × ULN, (B) mGH <1.0 μg/L, and (C) IGF-I <1.0 × ULN at week 36, in all patients and by screening mean GH level.